Please ensure Javascript is enabled for purposes of website accessibility

Why Shares of Cresco Labs Are Down This Week

By Bram Berkowitz – Sep 9, 2021 at 3:04PM

Key Points

  • The study examined more than 33,000 young adults and found that heart attacks were more frequent among cannabis users.

Motley Fool Issues Rare “All In” Buy Alert

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Many cannabis stocks have declined after a new report showed there could be a link between cannabis use and heart attacks.

What happened

Shares of the medical marijuana company Cresco Labs (CRLBF -5.72%) had fallen roughly 12% this week, as of 2:35 p.m. EDT, for no obvious reason other than negative sentiment in the broader sector.

So what

The main reason marijuana stocks seem to be struggling has to do with a recent report from the Canadian Medical Association Journal that found a link between the use of marijuana and heart attacks.

The study looked at more than 33,000 young adults, ages 18-44, and found that a history of heart attacks was more frequent among cannabis users.

Robert Page, chairman of the American Heart Association, also issued a statement recently that said that cannabis can also interact with many cardiovascular medications such as blood thinners.

Red stock chart arrow moving downward.

Image source: Getty Images.

Now what

Cresco recently completed the acquisition of Cultivate, a Massachusetts cannabis cultivator, and not too long ago reported earnings results for the second quarter that handily beat estimates from analysts.

While this recent news from the Canadian Medical Association Journal is certainly alarming and should make users think about whether using marijuana is appropriate with their specific health conditions, I do find it unlikely that the study will significantly curb marijuana use long term. This leads me to believe that if you like the company's fundamentals, then this could be an opportune time to buy the stock.

Bram Berkowitz has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Cresco Labs Inc. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Cresco Labs Inc. Stock Quote
Cresco Labs Inc.
CRLBF
$3.13 (-5.72%) $0.19

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
356%
 
S&P 500 Returns
118%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.